K-State researchers work may prevent unnecessary vaccinations in at-risk pets.
Researchers at Kansas State University's Veterinary Diagnostic Laboratory have modified a test that measures an animal's immune response to the rabies virus, a change that could cost pet owners less money and could help reduce the number of yearly vaccines for pets, according to a university release.
The researchers say testing for titers-the antibodies capable of neutralizing rabies-is a valid indication of the animal's resistance to the rabies virus. A measurement of 0.5 international units per milliliter or higher would indicate that the pet is protected and may only need a booster if exposed to the virus, depending on rabies regulations in the area, the release states.
All animals should be vaccinated with core vaccines and receive a yearly booster of those vaccines. But yearly vaccines can sometimes create other health concerns; for example, there is a link between yearly vaccinations and injection site sarcomas in cats. The K-State rabies titer test could keep a pet from experiencing an unnecessary injection at its yearly exam.
The test has not yet been accepted by national veterinary organizations as a standard for indicating a pet's level of protection against rabies, but measuring titers is currently used for determining whether cats and dogs need a vaccination for other high-risk diseases, the release states.
"In both domestic cats and dogs, there is a positive correlation between rabies neutralizing antibody titers and the level of protection,” says Rolan Davis, MS, a researcher in the Kansas State University Rabies Laboratory. "We are certainly not against vaccinations; we are against rabies. We are looking for the best ways to prevent rabies in animals and humans."
From poultry to public health: Understanding the H5N1 threat
October 29th 2024Veterinary and public health officials share the important roles of surveillance and prevention strategies, insights on the virus's transmission pathways, historical context, the One Health approach, and highlights effective precautionary measures to mitigate H5N1 risks.
Read More
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More